MX2018000984A - Terapias de combinacion. - Google Patents
Terapias de combinacion.Info
- Publication number
- MX2018000984A MX2018000984A MX2018000984A MX2018000984A MX2018000984A MX 2018000984 A MX2018000984 A MX 2018000984A MX 2018000984 A MX2018000984 A MX 2018000984A MX 2018000984 A MX2018000984 A MX 2018000984A MX 2018000984 A MX2018000984 A MX 2018000984A
- Authority
- MX
- Mexico
- Prior art keywords
- combination therapies
- polypeptide
- compositions
- treating
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Virology (AREA)
- Dentistry (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15178209.1A EP3120866A1 (en) | 2015-07-24 | 2015-07-24 | Use of marine serine proteases for removal, prevention and inhibition of formation and growth of biofilms |
| PCT/EP2016/067570 WO2017017027A1 (en) | 2015-07-24 | 2016-07-22 | Combination therapies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018000984A true MX2018000984A (es) | 2018-08-09 |
Family
ID=53785469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018000984A MX2018000984A (es) | 2015-07-24 | 2016-07-22 | Terapias de combinacion. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11338021B2 (https=) |
| EP (2) | EP3120866A1 (https=) |
| JP (1) | JP2018521143A (https=) |
| KR (1) | KR20180031704A (https=) |
| CN (1) | CN107921102B (https=) |
| AU (1) | AU2016301021B2 (https=) |
| CA (1) | CA2992677A1 (https=) |
| DK (1) | DK180380B1 (https=) |
| ES (1) | ES2989635T3 (https=) |
| MX (1) | MX2018000984A (https=) |
| RU (1) | RU2725800C2 (https=) |
| WO (1) | WO2017017027A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201701315D0 (en) | 2017-01-26 | 2017-03-15 | Enzymatica Ab | Novel treatments |
| WO2020229521A1 (en) * | 2019-05-14 | 2020-11-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for inhibiting or reducing bacterial biofilms on a surface |
| CN115666512A (zh) * | 2020-05-13 | 2023-01-31 | 智密科技公司 | 用于治疗微生物感染的蛋白酶制剂 |
| CN119499437A (zh) * | 2024-11-27 | 2025-02-25 | 武汉大学中南医院 | 一种负载胰蛋白酶抗细菌生物膜的温敏性水凝胶敷料及其制备方法与应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| SE459005B (sv) | 1985-07-12 | 1989-05-29 | Aake Rikard Lindahl | Saett att framstaella sfaeriska polymerpartiklar |
| CA2192782C (en) | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production of microspheres |
| US20020037260A1 (en) * | 1997-10-16 | 2002-03-28 | Budny John A. | Compositions for treating biofilm |
| RU2264824C2 (ru) | 1999-06-18 | 2005-11-27 | Йон Браги БЬЯРНАСОН | Сериновые протеиназы рыб и их фармацевтическое и косметическое применение |
| GB0205593D0 (en) * | 2002-03-09 | 2002-04-24 | Univ Nottingham | Treatment of surfaces populated by bacteria |
| EP2504025A4 (en) | 2009-11-23 | 2013-05-01 | Stephen F Olmstead | COMPOSITIONS AND METHODS USING SERRATIA PEPTIDASE FOR INHIBITING AND TREATING BIOFILMS ASSOCIATED WITH PARTICULAR SUFFERING |
| EP2714719B1 (en) | 2011-05-31 | 2018-12-12 | Hutchison Biofilm Medical Solutions Limited | Dispersion and detachment of cell aggregates |
| CN103007258A (zh) | 2011-09-22 | 2013-04-03 | 安淇生物控释技术(苏州)有限公司 | 含鱼丝氨酸蛋白酶和抗菌化合物的医用组合物及其用途 |
| MX349991B (es) * | 2011-12-21 | 2017-08-22 | Colgate Palmolive Co | Composiciones de cuidado oral. |
| CN103191491A (zh) * | 2012-01-10 | 2013-07-10 | 查红梅 | 一种包装物及其用途和制法 |
| BR112014027818B1 (pt) | 2012-05-09 | 2023-03-28 | Contrafect Corporation | Usos de composições compreendendo polipeptídeo de lisina para prevenção, ruptura ou tratamento de um biofilme bacteriano |
| WO2013170128A1 (en) * | 2012-05-11 | 2013-11-14 | Smith & Nephew, Inc. | Use of seaprose to remove bacterial biofilm |
| CN203090136U (zh) * | 2013-02-02 | 2013-07-31 | 成都玺汇科技有限公司 | 一种口鼻两用喷雾器 |
| ES2890555T3 (es) * | 2014-01-29 | 2022-01-20 | Enzymatica Ab | Tripsina de bacalao para uso en el tratamiento de infecciones microbianas en un sujeto con inmunodeficiencia |
| GB201405784D0 (en) * | 2014-03-31 | 2014-05-14 | Enzymatica Ab | Novel methods, polypeptides and uses thereof |
-
2015
- 2015-07-24 EP EP15178209.1A patent/EP3120866A1/en not_active Withdrawn
-
2016
- 2016-07-22 EP EP16751512.1A patent/EP3325002B1/en active Active
- 2016-07-22 CA CA2992677A patent/CA2992677A1/en active Pending
- 2016-07-22 KR KR1020187004149A patent/KR20180031704A/ko not_active Withdrawn
- 2016-07-22 JP JP2018522872A patent/JP2018521143A/ja active Pending
- 2016-07-22 CN CN201680042973.9A patent/CN107921102B/zh active Active
- 2016-07-22 MX MX2018000984A patent/MX2018000984A/es unknown
- 2016-07-22 WO PCT/EP2016/067570 patent/WO2017017027A1/en not_active Ceased
- 2016-07-22 US US15/746,888 patent/US11338021B2/en active Active
- 2016-07-22 AU AU2016301021A patent/AU2016301021B2/en not_active Ceased
- 2016-07-22 RU RU2018106490A patent/RU2725800C2/ru active
- 2016-07-22 ES ES16751512T patent/ES2989635T3/es active Active
-
2018
- 2018-01-23 DK DKPA201870043A patent/DK180380B1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018106490A (ru) | 2019-08-26 |
| EP3325002B1 (en) | 2024-09-04 |
| US20200085921A1 (en) | 2020-03-19 |
| DK201870043A1 (en) | 2018-02-05 |
| US11338021B2 (en) | 2022-05-24 |
| WO2017017027A1 (en) | 2017-02-02 |
| AU2016301021B2 (en) | 2022-11-10 |
| EP3325002C0 (en) | 2024-09-04 |
| CN107921102A (zh) | 2018-04-17 |
| EP3120866A1 (en) | 2017-01-25 |
| KR20180031704A (ko) | 2018-03-28 |
| CN107921102B (zh) | 2022-09-09 |
| EP3325002A1 (en) | 2018-05-30 |
| BR112018001391A2 (en) | 2018-09-11 |
| RU2725800C2 (ru) | 2020-07-06 |
| RU2018106490A3 (https=) | 2020-01-24 |
| ES2989635T3 (es) | 2024-11-27 |
| CA2992677A1 (en) | 2017-02-02 |
| DK180380B1 (en) | 2021-03-17 |
| AU2016301021A1 (en) | 2018-02-01 |
| JP2018521143A (ja) | 2018-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021000710A (es) | Composiciones que comprenden cepas bacterianas. | |
| MX2021000077A (es) | Composiciones que comprenden cepas bacterianas. | |
| MX2022004304A (es) | Agentes inductores de apoptosis. | |
| MX2018006398A (es) | Composiciones que comprenden cepas bacterianas. | |
| MX2017016525A (es) | Composiciones que comprenden cepas bacterianas. | |
| MD3240554T2 (ro) | Blautia stercosis și wexlerae pentru utilizare în tratarea bolilor inflamatorii și autoimune | |
| GEAP202014670A (en) | Agents, Uses and Methods for the Treatment of Synucleinopathy | |
| MX2019004500A (es) | Terapia de combinación para la inhibición de componente de complemeto (c3). | |
| SG10201808940WA (en) | Nox inhibitor and nfкb inhibitor containing methoxyflavone | |
| AU2018347307A1 (en) | Heterocyclic compounds and uses thereof | |
| MX2025010681A (es) | Formulaciones transdermicas | |
| PH12017501990B1 (en) | Imidazopyrazinones as pde1 inhibitors | |
| MX2019010984A (es) | Composiciones de sintecina y metodos de uso. | |
| MX2021006326A (es) | Inhibidores de pcna. | |
| MX2020004118A (es) | Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas. | |
| MX2019006552A (es) | Terapia génica para mucopolisacaridosis de tipo i. | |
| PH12018501455A1 (en) | Therapeutic compostions and methods for treating hepatitis b | |
| PH12017501864A1 (en) | Compositions and methods for treating autism | |
| PH12017501022B1 (en) | Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same | |
| MX2019006551A (es) | Terapia génica para mucopolisacaridosis de tipo ii. | |
| MX2017016114A (es) | Metodos para tratar o prevenir una proteopatia. | |
| MX2018000984A (es) | Terapias de combinacion. | |
| ZA202211980B (en) | Methods and treatment of trauma | |
| PH12016501938A1 (en) | Halogenated quinazolin-thf-amines as pde1 inhibitors | |
| PH12016501838A1 (en) | Compounds and their methods of use |